Acknowledgement
본 연구는 2022년도 부산대학교병원 임상연구비 지원으로 이루어졌음.
References
- Suk KT, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol 2012 Sep;18(3):249-57. https://doi.org/10.3350/cmh.2012.18.3.249
- CIOMS Consensus report on Drug-Induced Liver Injury (DILI) Available from https://cioms.ch/wp-content/uploads/2020/07/CIOMS-CoRE-July-Webinar-SlideDeck_Final23Jul2020.pdf
- Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology 2023;77(3):1036-65. https://doi.org/10.1002/hep.32689
- Jin SE, Jeong SJ, Shin HK, Ha H. Hepatoprotective effects of 25 herbal formulas in primary rat hepatocytes. JPPKM 2013;27(5):617-24.
- Kwon JY, Kim YJ, Park JK, Kong KH, Go HY. A case report of suggested liver dysfunction by atorvastatin treated with Saenggangeonbi-tang. J Int Korean Med 2017;38(5):548-54. https://doi.org/10.22246/jikm.2017.38.5.548
- Choi HS, Jung TY. One Case of Drug-Induced Liver Injury Treated with Saenggangeonbi-tang. J Int Korean Med 2004;25(4):207-11.
- Choi JW, Bae CW, Park SY, Yun HJ, Park SD. Protective effect of injinhotang and its components on acetaminophen-induced hepatoxicity in rats. Herbal formula science 2005;13(1):9-33.
- Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46(11):1323-30. https://doi.org/10.1016/0895-4356(93)90101-6
- Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers 2016;2:16076.
- Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350(20):2060-7. https://doi.org/10.1056/NEJMsa031667
- Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3(10):847-50.
- Latent tuberculosis infection: updated and consolidated guidelines for programmatic management [Internet]. Available from https://www.who.int/publications/i/item/9789241550239 (Access 2023.09.05.)
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Available from https://www.ncbi.nlm.nih.gov/books/NBK547852/ (Access 2023.09.05.)
- Lang SM, AI-Nemnem E, Schiffl H. Anti-tuberculosis drug induced liver injury and ursodeoxycholic acid. Journal of Tuberculosis Research 2020;8(20):66-72. https://doi.org/10.4236/jtr.2020.82007
- Saito Z, Kaneko Y, Kinoshita A, Kurita Y, Odashima K, Horikiri T, et al. Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis. BMC Infect Dis 2016;16(1):668.
- Wikipedia. Available from: https://zh.wikipedia.org/wiki/%E5%BC%B5%E4%BB%B2%E6%99%AF. (Access 2023.09.05.)
- 何伦. 实用处方纲目. 1st edition. 陜西: 陜西科学技术出版社; 1991, p. 427-9.
- Park KJ, Kang HK, Han CW. Clinical effect of Injinho-tang on hyperbilirubinemia in hepatobiliary disorders: a systematic review. J Int Korean Med 2022;43(6):1149-61. https://doi.org/10.22246/jikm.2022.43.6.1149
- Yang Q, Yang F, Tang X, Ding L, Xu Y, Xiong Y, et al. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang. BMC Complement Altern Med 2015;15:122.
- Tao W, Zhu W, Nabi F, Li Z, Liu J. Penthorum chinense Pursh compound flavonoids supplementation alleviates Aflatoxin B1-induced liver injury via modulation of intestinal barrier and gut microbiota in broiler. Ecotoxicol Environ Saf 2023;255:114805.
- Mase A, Makino B, Tsuchiya N, Yamamoto M, Kase Y, Takeda S, et al. Active ingredients of traditional Japanese (kampo) medicine, inchinkoto, in murine concanavalin A-induced hepatitis. J Ethnopharmacol 2010;127(3):742-9. https://doi.org/10.1016/j.jep.2009.11.029
- Yan J, Xie G, Liang C, Hu Y, Zhao A, Huang F, et al. Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats. Sci Rep 2017 Jun 23;7(1):4211.
- Zhang H, Wang X, Hu P, Zhou W, Zhang M, Liu J, et al. Serum metabolomic characterization of liver fibrosis in rats and anti-fibrotic effects of Yin-Chen-Hao-Tang. Molecules 2016;21(1):E126.
- Korean Guidelines For Tuberculosis Fourth Edition. Available from: https://www.medric.or.kr/Uploads/BLibrary/%EA%B2%B0%ED%95%B5%EC%A7%84%EB%A3%8C%EC%A7%80%EC%B9%A8(4%ED%8C%90)(2020).pdf